Company intelligence / Profile preview

Circularity Healthcare

Pasadena, California, United Statescircularityhealthcare.com ↗

Ownership: Private
Development stage: Commercial

Overview

Circularity Healthcare's lead product D'OXYVA has demonstrated positive clinical results in improving microcirculation and wound healing with a strong safety profile. The company reports randomized human clinical evidence and long-term user feedback with no reported adverse side effects. It operates globally with regulatory approvals in multiple countries and ongoing efforts to expand FDA-cleared indications.

Therapeutic areas: PulmonologyEndocrinologyDermatologyCardiovascularNeurology
Modalities: DeviceNon-pharmacological therapyTransdermal delivery system
Industry: Therapeutic Medical Devices

Partnerships

Not specifically listed in public sources.

Beyond the preview

Go deeper on Circularity Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Circularity Healthcare.

Explore the full profile